Managing the Surge of Weight Loss Prescriptions
Managing the Surge of Weight Loss Prescriptions
Managing Weight Loss Prescription Approvals
What began as a medical treatment for type 2 diabetes and metabolic issues has rapidly transformed into a sought-after weight loss solution. Glucagon-like peptide-1 (GLP-1) receptor agonists, like Ozempic and Wegovy, have proven to be an effective, less invasive option to address obesity.
The remarkable results have also led to new business models. Retailers, marketplaces and wellness brands are embedding these medications into their core offerings, while influencer buzz and off-brand compounds have supercharged demand far beyond medical users.
A critical tension has emerged, overwhelming providers: Supply chains have stabilized, but they now face crushing pressure while working to maintain strict prescription controls. Each request requires careful verification to prevent misuse, creating a massive backlog.
Healthcare outsourcing can help organizations address the challenges and meet compliance.
Download the white paperReferences
